These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31899815)

  • 21. BRAF V600E mutation mediates invasive and growth features in ameloblastoma.
    Zhang CX; Zhang LZ; Lin H; Man QW; Liu B
    Oral Dis; 2024 Oct; 30(7):4426-4439. PubMed ID: 38424736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRAF p.V600E mutations are not unique to ameloblastoma and are shared by other odontogenic tumors with ameloblastic morphology.
    Brunner P; Bihl M; Jundt G; Baumhoer D; Hoeller S
    Oral Oncol; 2015 Oct; 51(10):e77-8. PubMed ID: 26306423
    [No Abstract]   [Full Text] [Related]  

  • 23. [Research advances in the v-raf murine sarcoma viral oncogene homolog gene mutation in ameloblastoma].
    Yan XC; Sun LS; Dong ZW; You Z; Dong Q
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Jul; 53(7):500-502. PubMed ID: 29996373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ameloblastic Fibrosarcoma of the Jaw: Case Report, Genetic Profiling, and Literature Review.
    Barakeh D; Alsolami A; Abedalthagafi M
    Case Rep Oncol; 2023; 16(1):1293-1299. PubMed ID: 37942402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.
    Heppt MV; Siepmann T; Engel J; Schubert-Fritschle G; Eckel R; Mirlach L; Kirchner T; Jung A; Gesierich A; Ruzicka T; Flaig MJ; Berking C
    BMC Cancer; 2017 Aug; 17(1):536. PubMed ID: 28797232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ameloblastic fibrosarcoma of the mandible: report of 2 chemosensitive pediatric cases.
    Demoor-Goldschmidt C; Minard-Colin V; Cassagneau E; Supiot S; Oberlin O; D'hautuille C; Corradini N
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):e72-6. PubMed ID: 22009005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
    Lázár V
    Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAPK/ERK signal pathway alterations in patients with Langerhans Cell Histiocytosis.
    Novosad O; Skrypets T; Pastushenko Y; Titorenko I; Martynchyk A; Skachkova O; Inomistova M; Gorbach A; Khranovska N; Kryachok I
    Klin Onkol; 2018; 31(2):130-136. PubMed ID: 29708356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis.
    Park SJ; Sun JY; Hong K; Kwak JY; Kim EK; Chung WY; Choi JR
    Clin Chem Lab Med; 2013 Aug; 51(8):1673-80. PubMed ID: 23585181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and detection of actionable BRAF V600 and NRAS Q61 mutations in malignant peripheral nerve sheath tumor by droplet digital PCR.
    Kao EY; Wakeman KM; Wu Y; Gross JM; Chen EY; Ricciotti RW; Liu YJ; Mantilla JG
    Hum Pathol; 2022 Nov; 129():90-97. PubMed ID: 36067829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAF-V600E expression correlates with ameloblastoma aggressiveness.
    Fregnani ER; Perez DE; Paes de Almeida O; Fonseca FP; Soares FA; Castro-Junior G; Alves FA
    Histopathology; 2017 Feb; 70(3):473-484. PubMed ID: 27681305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological characteristics and diagnostic accuracy of BRAF mutations in ameloblastoma: A Bayesian network analysis.
    Zhang AB; Zhang JY; Liu YP; Wang S; Bai JY; Sun LS; Li TJ
    J Oral Pathol Med; 2024 Jul; 53(6):393-403. PubMed ID: 38777565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: Clinicopathological significance and correlation with epithelial-mesenchymal transition.
    Oh KY; Cho SD; Yoon HJ; Lee JI; Ahn SH; Hong SD
    J Oral Pathol Med; 2019 May; 48(5):413-420. PubMed ID: 30889301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ Spectrum of oncogene mutations is different in melanoma subtypes].
    Mazurenko NN; Tsyganova IV; Lushnikova AA; Ponkratova DA; Anurova OA; Cheremushkin EA; Mikhailova IN; Demidov LV
    Mol Biol (Mosk); 2015; 49(6):1022-9. PubMed ID: 26710785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.
    Uguen A; Talagas M; Costa S; Samaison L; Paule L; Alavi Z; De Braekeleer M; Le Marechal C; Marcorelles P
    Diagn Pathol; 2015 Jul; 10():121. PubMed ID: 26204954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological characteristics and mutation profile of BRAF and NRAS mutation in cutaneous melanomas in the Western Turkish population.
    Evrenos MK; Temiz P; Çam FS; Yaman M; Yoleri L; Ermertcan AT
    Turk J Med Sci; 2018 Oct; 48(5):973-979. PubMed ID: 30384563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The BRAF p.V600E mutation is a common event in ameloblastomas but is absent in odontogenic keratocysts.
    Zhang R; Yang Q; Qu J; Hong Y; Liu P; Li T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):229-235. PubMed ID: 31987674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
    Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
    J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Outcomes in Codon 12/13 and Codon 61
    Cleary JM; Wang V; Heist RS; Kopetz ES; Mitchell EP; Zwiebel JA; Kapner KS; Chen HX; Li S; Gray RJ; McShane LM; Rubinstein LV; Patton DR; Meric-Bernstam F; Dillmon MS; Williams PM; Hamilton SR; Conley BA; Aguirre AJ; O'Dwyer PJ; Harris LN; Arteaga CL; Chen AP; Flaherty KT
    Clin Cancer Res; 2021 Jun; 27(11):2996-3004. PubMed ID: 33637626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ameloblastic fibroma and ameloblastic fibrosarcoma: A systematic review.
    Chrcanovic BR; Brennan PA; Rahimi S; Gomez RS
    J Oral Pathol Med; 2018 Apr; 47(4):315-325. PubMed ID: 28776760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.